[Magdalen] Today, PCP appt.

[Jay Weigel]

One point, David, with all due respect, is that specialists DO NOT TALK to
one another. I noticed this from the time I was a very new nurse. I would
look at orders on a patient's chart and find that two different doctors had
written an order for the same labs, or the same test, on the very same
day.....denoting that they had not read one another's notes, or talked to
each other...and I knew that sometimes they had been making rounds at the
very same time, when they could have! I continued to note this throughout
my career, and it didn't seem to matter whether it was a busy teaching
hospital or a small town one.....the docs, in general, and especially the
specialists, just don't talk to each other! As a result, nobody seems to
have the whole picture. The PCP, who is supposed to be able to put the
pieces all together, often is so busy s/he doesn't have time to catch up.
My brother, who is an internist and does his level best to keep current,
tells me that for every 5 years you're out of med school you lose a couple
of years of updates. So there we are.

On Fri, Jul 15, 2016 at 12:16 PM, Lynn Ronkainen <houstonklr at gmail.com>
wrote:

> I think they've been tweaked enough to reduce early symptoms and more than
> a few years out mfgs can deny involvement of Rx
> Lynn
>
> Sent from my iPhone
>
> On Jul 15, 2016, at 10:50 AM, Cantor03--- via Magdalen <
> magdalen at herberthouse.org> wrote:
>
>
>
> In a message dated 7/15/2016 11:27:21 A.M. Eastern Daylight Time,
> jay.weigel at gmail.com writes:
>
> Copy,  print and take to your doctor,  Allan.>>>>>>>>>>>>>>>>>>>
>
>
> With disabling neuropathy this is good advice to cover all the bases.
>
> However, 14 years have passed since this article, and if the statins  were
> an important neuropathic disabler, their use would have been long  since
> severely curtailed.
>
> I suppose through the years I saw thousands of patients with elevated
> lipids,
> and I got the distinct impression that if statins were  discontinued for
> whatever reason, it was very difficult to reproduce their therapeutic
> effect on the lipids with another scheme.
>
> So if there is any message here is that I would be very, very sure  that
> bothersome symptoms are due to the statins before they are  discontinued,
> and that is especially true for diabetics.
>
> The statins have made their economic impact on the practice of
> dermatology.  I used to have the easy surgical removal of  xanthelasmas
> as one of my "bread and butter" procedures, but in the last 15 years  or
> so of practice, the occurrence of these dried up completely.   Patients
> no longer had hyperlipidemia because they were all taking statins,
> and they no longer had xanthelasmata.
>
>
> David Strang.
>
>
>
>